Senior Director of Business Development

About Acadia Pharmaceuticals Acadia Pharmaceuticals is dedicated to transforming scientific innovation into impactful solutions for underserved communities affected by neurological and rare diseases across the globe. Our commercial portfolio features the pioneering and sole FDA-approved treatments for Parkinson's disease psychosis and Rett syndrome. We are a…

Integrated Resources, Inc. is seeking a dynamic and experienced Director of Business Development to spearhead our growth initiatives. In this pivotal role, you will be responsible for identifying new business opportunities, forging strategic partnerships, and driving revenue growth in line with our corporate objectives. Your leadership will be essential in expanding our market presence and ensuring the successful execution of our business strategies.

About UsKardigan is an innovative heart health company dedicated to transforming the landscape of cardiovascular disease, making it preventable and curable, and ultimately eliminating it as the leading cause of death worldwide.Our mission is to develop a range of targeted treatments simultaneously to ensure that individuals suffering from cardiovascular diseases receive the cures they truly deserve.Founded by experts Tassos Giannakakos, Jay Edelberg, M.D., Ph.D., and Bob McDowell, Ph.D., who previously led MyoKardia in the groundbreaking development of mavacamten—the first cardiac myosin inhibitor acquired by Bristol Myers Squibb in 2020—we have established a state-of-the-art discovery and translational research platform paired with a robust pipeline of late-stage candidates. Our team is passionately committed to enhancing patient outcomes.At Kardigan, our core values guide our operations and interactions. We are driven by patients and their families, authentically engaging with each other to foster a supportive work environment. Our eagerness to learn fosters curiosity and adaptability. We believe in winning as a team, demonstrating urgency and excellence, and supporting one another regardless of our roles. We also strive to enable the impossible, taking calculated risks to unlock innovation and promote scientific advancements.

Kardigan is dedicated to transforming heart health by developing treatments aimed at preventing and curing cardiovascular disease. The company’s mission is to end cardiovascular disease as the world’s leading cause of death. Multiple targeted therapies are in development, with a focus on delivering effective solutions for people affected by cardiovascular conditions. Kardigan’s leadership includes Tassos Gianakakos, Jay Edelberg, M.D., Ph.D., and Bob McDowell, Ph.D. This team previously led MyoKardia, where their work resulted in the discovery of mavacamten, the first cardiac myosin inhibitor, and culminated in MyoKardia’s acquisition by Bristol Myers Squibb in 2020. With a modern research platform and a strong pipeline of late-stage candidates, Kardigan is positioned to improve outcomes for patients living with heart disease. Values Patient-centric: Every decision prioritizes patients and their families. Authenticity: The culture encourages acceptance and values each individual. Curiosity: Ongoing learning and openness to new perspectives are encouraged. Team success: Collaboration, urgency, and shared achievement are essential for results. Enable the impossible: Innovation and thoughtful risk-taking drive scientific advancement. These values shape daily work and support Kardigan’s efforts to make a lasting difference in heart health.

We are seeking a highly experienced and strategic Senior Director of Drug Substance Development to lead our innovative team at Kardigan in Princeton, New Jersey. In this pivotal role, you will spearhead the development of drug substances from early-stage formulation through to commercialization, ensuring that our products meet the highest standards of quality and efficacy. The ideal candidate will possess a deep understanding of drug development processes, project management, regulatory requirements, and cross-functional collaboration. You will drive initiatives that enhance productivity and foster a culture of scientific excellence, providing mentorship and guidance to team members.

Join Acadia Pharmaceuticals Inc. as the Senior Director of R&D Outsourcing and Business Optimization, where you will play a pivotal role in enhancing our research and development capabilities. You will lead strategic initiatives to optimize business processes and manage outsourcing operations, ensuring our projects align with our mission to advance innovative therapies for patients.

About Kardigan Kardigan focuses on heart health, working to make cardiovascular disease preventable and curable. The company aims to remove heart disease from its place as the world’s leading cause of death. Founded by Tassos Gianakakos, Jay Edelberg, M.D., Ph.D., and Bob McDowell, Ph.D., Kardigan draws on their experience at MyoKardia, where they helped discover mavacamten, the first cardiac myosin inhibitor. MyoKardia’s work led to an acquisition by Bristol Myers Squibb in 2020. The team operates a discovery and translational research platform, with a strong pipeline of late-stage candidates. The company values patient-centered care, authenticity, curiosity, teamwork, and innovation. These principles shape both daily work and long-term goals. Role Overview Title: Senior Director, People & Culture Business Partner Department: People & Culture Location: Princeton, NJ (On-site 4 days per week) Reports to: VP, People & Culture Type: Contract to Hire

Kardigan is dedicated to improving heart health by pursuing both prevention and cures for cardiovascular disease. The company aims to develop several targeted treatments at once, ensuring people with cardiovascular conditions have more options for care. Founded by Tassos Gianakakos, Jay Edelberg, M.D., Ph.D., and Bob McDowell, Ph.D., Kardigan's leadership previously led MyoKardia to discover and develop mavacamten, the first cardiac myosin inhibitor, which was acquired by Bristol Myers Squibb in 2020. Today, the team continues to advance cardiovascular medicine through a strong research platform and a late-stage pipeline focused on patient outcomes. Our Values Patient-centric: Every decision starts with the needs of patients and their families. Authenticity: Honesty and acceptance shape the work environment. Curiosity: Learning and adapting are part of daily work. Collaborative success: Team members support each other, no matter their role. Unlocking innovation: The team embraces risk to advance care, knowing patients depend on progress. These values guide daily work and reflect the impact the team aims to achieve.

Kyowa Kirin is an innovative and rapidly expanding global specialty pharmaceutical company that leverages cutting-edge biotechnologies to discover and deliver groundbreaking medicines across four key therapeutic areas: bone and mineral, intractable hematologic conditions, hematology oncology, and rare diseases. Headquartered in Princeton, New Jersey, we pride ourselves on our mission to transform scientific advancements into impactful therapies, particularly in areas where treatment options are limited. Our North American operations extend across various locations, including California, North Carolina, and Mississauga, Ontario.Position Overview:The Senior Director of GRA Development & Product Strategy Team Lead will spearhead the formulation and execution of regulatory strategies while leading a talented team and overseeing global projects. This pivotal role includes managing a team of Global Regulatory Leads (GRLs) and may involve acting as a Regional Regulatory Lead (RRL) as dictated by business needs.Key Responsibilities:Develop and implement comprehensive global regulatory strategies for all products within the designated disease area, ensuring alignment with corporate objectives and maximizing the value of products.Lead and cultivate a high-performing team of Global Regulatory Leads (GRLs), providing direction and building capabilities to foster an accountable culture.Integrate regulatory strategies into global product development and lifecycle plans in close collaboration with cross-functional partners.Ensure the successful execution of regulatory strategies, encompassing global submissions, approvals, and post-approval activities for assigned products and projects.Represent the organization in engagements with health authorities, leading negotiations and overseeing agency meeting strategies.Oversee and approve global regulatory submission plans, including marketing applications and key lifecycle deliverables.Coordinate regulatory activities, timelines, and deliverables across internal teams and external partners to ensure timely execution.Maintain compliance with global regulatory requirements and internal policies, supporting inspections and audits.Monitor and communicate regulatory risks, emerging trends, and competitive intelligence, recommending mitigation strategies as necessary.Drive operational excellence by leading process improvements and standardization efforts.

Noom is dedicated to empowering individuals to lead healthier, longer lives. As an innovative digital health company, we connect our users with valuable content, personalized coaching, community support, and medical professionals to foster sustainable health habits. Our organization thrives on a foundation of scientific research, cutting-edge technology, and exceptional talent, ensuring that every team member can witness the meaningful impact of their contributions.About the RoleAs part of our expansion, we are looking for a Senior Director of Clinical Operations to spearhead and enhance our clinical operations division. Reporting directly to the SVP of Health Operations and Customer Experience, you will inherit a dedicated team and an active portfolio of initiatives, while also creating new strategies. You will be responsible for overseeing clinical protocols, managing vendor relationships, and developing operational frameworks that bring Noom’s clinical programs to fruition for both B2B and direct-to-consumer markets.Your ResponsibilitiesOversee the comprehensive clinical operations organization for Noom Med, facilitating strategic growth in clinical programs, protocol development, and the execution of new initiatives alongside Product and Engineering teams.Act as the operational liaison between clinical strategy and implementation, ensuring that commitments to members and enterprise partners are met with excellence, accuracy, and quantifiable results.Build and lead a high-performing clinical operations team, managing recruitment strategies and headcount as the company scales.Drive the execution of clinical programs across D2C and B2B initiatives, fostering collaboration among internal clinical teams, external provider networks, and vendor partners.Ensure a positive provider and member experience, prioritizing provider satisfaction, clinical quality, and member health outcomes as key performance indicators.Establish and maintain the operational infrastructure that supports the clinical organization, including capacity models, utilization targets, reporting systems, and workflow processes that adapt to growth.Continuously evolve your role and responsibilities to meet the demands of Noom Med's expansion.

About Acadia Pharmaceuticals Acadia Pharmaceuticals is dedicated to transforming scientific potential into innovative solutions that significantly benefit underserved communities dealing with neurological and rare diseases globally. Our current commercial portfolio features the first and only FDA-approved treatments for Parkinson’s disease psychosis and Rett syndrome. We are actively developing a diverse pipeline of therapeutic advancements, which includes mid- to late-stage programs targeting Alzheimer's disease psychosis and Lewy body dementia psychosis, alongside earlier-stage initiatives aimed at addressing various unmet patient needs. At Acadia, our mission is to make a difference in the lives of these patients.Seeking talent near: Princeton, NJPosition SummaryThe Associate Director of Drug Product Development will lead the formulation, primary packaging, and manufacturing process development for Acadia’s expanding portfolio of drug candidates across all development phases. This role involves providing technical oversight, expertise, and guidance for outsourced drug product development activities. The responsibilities encompass the development of formulations, packaging, and processes for various administration routes, including oral solid, liquid, and injectable dosage forms, managing candidates from clinical development through to process validation and lifecycle management. The successful candidate will oversee activities related to these tasks at Contract Service Providers (CSPs) and play a pivotal role in addressing complex technological challenges while implementing new manufacturing technologies for products intended for clinical and commercial distribution. This position is vital for optimizing development, mitigating risks, and expediting the launch of new assets into the market.Primary ResponsibilitiesDesign and develop pharmaceutical formulations and manufacturing processes to support clinical trials, regulatory submissions, and product launches.Evaluate and validate new drug product Contract Service Providers (CSPs) to facilitate development, scaling, and commercialization of new drug candidates within Acadia’s pipeline. Initiate and manage supplier contract agreements as necessary.

About Acadia Pharmaceuticals Acadia Pharmaceuticals focuses on turning scientific discoveries into meaningful treatments for people with neurological and rare diseases. The company’s commercial portfolio includes the first and only FDA-approved therapies for Parkinson’s disease psychosis and Rett syndrome. Acadia continues to expand its pipeline, with mid- to late-stage programs in Alzheimer’s disease psychosis and Lewy body dementia psychosis, as well as earlier-stage research targeting additional unmet needs. Location and Hybrid Work Model This Senior Director of Portfolio Management role may be based in Princeton, NJ, San Diego, CA, or South San Francisco, CA. Acadia uses a hybrid work model, with an average of three days per week in the office required for this position. Role Overview The Senior Director of Portfolio Management shapes and executes the strategic direction of Acadia’s development and commercialization portfolio. Working in a matrixed environment, this leader drives portfolio prioritization across the enterprise, builds cross-functional partnerships, and supports effective decision-making to maximize value. The role requires close collaboration with teams in Finance, R&D, and Commercial to ensure portfolio investments align with scientific goals, market needs, and financial discipline. Key Responsibilities Create and apply portfolio prioritization frameworks that balance scientific innovation, commercial opportunity, and financial impact. Partner with Finance to assess investment scenarios, improve resource allocation, and support financially sound portfolio decisions. Work alongside R&D leadership to align pipeline strategy with overall portfolio objectives, focusing on scientific feasibility and milestone-based progress. Collaborate with Commercial teams to incorporate market insights, competitive analysis, and launch planning into product positioning strategies.

About Kardigan Kardigan focuses on heart health, working to shift cardiovascular disease from a global threat to a manageable condition. The company develops multiple targeted therapies at once, aiming to provide effective treatments for people living with cardiovascular diseases. Kardigan was founded by Tassos Gianakakos, Jay Edelberg, M.D., Ph.D., and Bob McDowell, Ph.D. The team previously led MyoKardia, where they developed mavacamten, the first cardiac myosin inhibitor. Their work led to MyoKardia's acquisition by Bristol Myers Squibb in 2020. The company uses advanced discovery and translational research platforms and has a pipeline of late-stage candidates. The team is committed to improving patient outcomes. Our Values Prioritize the well-being of patients and their families Embrace authenticity and foster inclusion Encourage learning, curiosity, and adaptability Support each other in striving for excellence Work together to achieve ambitious goals for patients These values shape daily work at Kardigan and support a lasting impact in the field of cardiovascular health.

About Acadia Pharmaceuticals Acadia Pharmaceuticals is dedicated to transforming scientific advancements into impactful innovations for the global community facing neurological disorders and rare diseases. Our approved treatments for Parkinson's disease psychosis and Rett syndrome set us apart as pioneers in the field. With a dynamic pipeline that addresses critical needs in Alzheimer's disease psychosis and Lewy body dementia psychosis, as well as ongoing early-stage programs, we strive to be the difference for those we serve.Talent sought in: Princeton, NJ; San Diego, CAPosition OverviewThe Associate Director within the Early Stage Drug Product Development team at Acadia will lead the formulation development of pharmaceutical products intended for early-phase clinical trials and preclinical studies. This role will closely collaborate with drug discovery teams to identify optimal drug candidates through comprehensive physicochemical analysis and property assessment. Focused on early development strategies, the successful candidate will ensure that formulations are primed for initial safety and efficacy evaluations. Collaboration with both internal scientists and external partners is vital to overcoming technical challenges and advancing promising compounds to clinical readiness.Additionally, the role involves managing activities at Contract Service Providers (CSPs) and contributing to the resolution of complex technological issues, ensuring the selection of viable drug candidates, mitigating risks, and accelerating the introduction of new chemical entities into Acadia's pipeline.Key Responsibilities Design and develop pharmaceutical formulations to facilitate early-stage clinical trials, incorporating rapid development options such as on-site compounding.Assess and validate new drug product CSPs (Contract Service Providers) to support...

We are seeking a highly skilled Senior Business Analyst to join our Clinical Operations team at Integrated Resources Inc. In this pivotal role, you will leverage your analytical expertise to support clinical projects and streamline operational processes. Your insights will guide decision-making and enhance project outcomes in a fast-paced and dynamic environment.

Ascendis Pharma is an innovative and rapidly expanding global biopharmaceutical firm with a presence in the United States, Denmark, and Europe. Our focus is on advancing pioneering programs in Endocrinology, Rare Diseases, and Oncology.At Ascendis, we take pride in our commitment to exceptional scientific research, visionary leadership, and a team of dedicated professionals. Our core values—Patients, Science, and Passion—drive our mission to develop novel therapies that address significant unmet medical needs through our cutting-edge TransCon® drug development platform.Our culture champions a dynamic environment where skilled, adaptable, and resourceful professionals can leave their mark. We provide an engaging workplace that nurtures employee growth and skill development.Position OverviewThe Senior Director will spearhead the U.S. Key Opinion Leader (KOL) engagement strategy across our endocrine portfolio, which includes managing healthcare professional peer-to-peer programs, congress strategies, and speaker bureau initiatives. Success in this role will be evaluated by the effectiveness of the annual KOL engagement plan, governance model, and the quality of peer-to-peer educational initiatives that enhance understanding of diseases and products. This leader will ensure all programs are executed on time, within budget, and in strict compliance with regulatory standards.We seek a leader with proven organizational leadership and people management experience, as well as robust strategic capabilities to excel in our entrepreneurial and growing organization. The Senior Director will lead a team of Thought Leader Liaisons and collaborate with cross-functional teams to deliver impactful KOL engagement and education initiatives that align with business priorities. Strong leadership, collaboration skills, and the ability to navigate through change are essential for this role.This position reports directly to the U.S. Vice President of Marketing and will play a vital role within the Marketing and Commercial Leadership Teams.

Kyowa Kirin, Inc. is a global specialty pharmaceutical company with a focus on developing and delivering medicines for bone and mineral disorders, intractable hematologic diseases, hematology oncology, and rare diseases. The North American headquarters is based in Princeton, New Jersey, with additional offices in California, North Carolina, and Mississauga, Ontario. Role overview The Senior Director, Head of North America Rare Disease, leads the medical and scientific strategy for the rare disease therapeutic area across the region. This position shapes the vision and priorities for the franchise, guiding activities from early development through launch and ongoing lifecycle management. The Senior Director works with diverse stakeholders and ensures the franchise strategy addresses both regional and global objectives. Key responsibilities Define and own the regional medical vision and long-term strategy for the rare disease therapeutic area, aligning with both global and regional priorities. Oversee strategy for all assets within the therapeutic area, ensuring consistency across development phases and in communication to target audiences. Serve as the primary regional medical authority and advisor to senior Medical Affairs and enterprise leadership for the therapeutic area. Maintain high standards for scientific quality, strategic alignment, and medical impact across the portfolio. Provide direct leadership and guidance to Asset Medical Leads and related teams. Collaboration and strategic alignment This role partners closely with Medical Affairs Operations and Excellence, MSL leadership, and Global Medical Affairs to ensure regional strategies stay in step with global goals. The Senior Director helps secure resources and supports effective implementation throughout the product lifecycle. While not directly managing Field Medical teams, this position sets strategic direction for MSL leadership and ensures delivery of high-quality scientific communication materials. Location: Princeton, New Jersey

About Acadia Pharmaceuticals Acadia Pharmaceuticals is dedicated to transforming scientific advancements into impactful innovations for underrepresented communities affected by neurological and rare diseases globally. We proudly offer the first and only FDA-approved treatments for Parkinson’s disease psychosis and Rett syndrome. Our commitment to innovation continues with a robust pipeline that includes advanced programs for Alzheimer’s disease psychosis and Lewy body dementia psychosis, alongside initiatives aimed at addressing other critical patient needs. At Acadia, we strive to make a real difference.Please note that this position is based in San Diego, CA or Princeton, NJ. Acadia's hybrid model requires this role to work in our office three days per week on average.Position Summary Acadia Pharmaceuticals is on the lookout for a highly experienced and strategic leader in Health Economics and Outcomes Research (HEOR) to join us as the Senior Director of HEOR. In this pivotal position, you will spearhead the creation and execution of comprehensive value evidence strategies that highlight the clinical, economic, and humanistic benefits of Acadia’s therapies throughout their lifecycle, from development to commercialization and global market access.As the demand for high-quality real-world evidence and outcomes research increases, your role will be vital in influencing health technology assessments, payer decision-making, reimbursement processes, and product differentiation. You will oversee the generation and communication of HEOR evidence, incorporating real-world evidence, economic modeling, and clinical outcomes assessments, to facilitate access and adoption across diverse global markets.The Senior Director of HEOR will craft and convey the value narrative for assigned products or indications, leading the development of global value dossiers, economic models, and HTA strategies that convincingly articulate the benefits of Acadia’s therapies to patients, healthcare systems, and public health decision-makers. This role necessitates close collaboration with various stakeholders to ensure alignment and success.

Kyowa Kirin is an innovative global specialty pharmaceutical company, leveraging cutting-edge biotechnologies to discover and deliver groundbreaking therapies across four key disease areas: bone and mineral disorders, intractable hematologic conditions, hematology oncology, and rare diseases. As a company rooted in Japan, our mission is to translate scientific advancements into meaningful patient outcomes by providing effective treatments where options are limited, spanning from drug discovery to product development and market entry. Our North American headquarters is located in Princeton, NJ, with additional offices in California, North Carolina, and Mississauga, Ontario.Position Overview:The Director of Pharmacometrics will spearhead a team of skilled Pharmacometricians within the Global Development Organization (GDO) and the Clinical Pharmacology (CP) function. This role combines direct project involvement with the mentorship of team members in the design and implementation of model-informed drug development (MIDD) strategies. Responsibilities include enhancing workflows and systems for delivering quantitative clinical pharmacology outputs. The Director will play a crucial role in educating project teams and organizational leadership on the significance of MIDD and quantitative clinical pharmacology strategies. Furthermore, the Director will explore collaborative opportunities with various Kyowa Kirin departments, such as Regulatory Affairs and Medical Affairs, to proliferate MIDD strategies throughout the development process and in post-marketing efforts.Key Responsibilities:Oversee pharmacometrics deliverables for project teams, ensuring scientific integrity, timeliness, and substantial impact; identify and capitalize on opportunities to elevate quantitative clinical pharmacology within the organization.Direct pharmacometrics strategy and guarantee high-quality preparation of pharmacometric components for scientific documentation, regulatory submissions, and responses to health authority inquiries.Provide scientific and technical guidance to pharmacometrics staff, ensuring excellence in modeling techniques and effective communication across all organizational tiers.Facilitate clear and impactful communication of pharmacometric and clinical pharmacology findings to diverse internal and external stakeholders.Collaborate with GDO Clinical Pharmacology colleagues and cross-functional partners to enhance efficiency, alignment, and innovation in drug development initiatives.

About Acadia Pharmaceuticals Acadia Pharmaceuticals focuses on turning scientific discoveries into meaningful treatments for underserved communities affected by neurological and rare diseases. The company’s commercial portfolio includes the first and only FDA-approved therapies for Parkinson’s disease psychosis and Rett syndrome. Acadia continues to advance a diverse pipeline, with mid- and late-stage programs for Alzheimer’s disease psychosis and Lewy body dementia psychosis, as well as early-stage efforts aimed at additional unmet needs. The team is committed to making a real difference in patients’ lives. Location and Work Model This position may be based in San Diego, CA, San Francisco, CA, or Princeton, NJ. Acadia offers a hybrid work model. Role Overview The Executive Director of Translational Sciences leads the design and execution of disease and drug mechanism of action (MoA) studies that advance therapeutics through clinical development. This position requires deep expertise in translational sciences and hands-on experience in rare diseases. Strong leadership and mentoring skills are essential, as well as a thorough understanding of clinical biomarker development and the full drug development process from discovery through late-stage clinical trials. Success in this role depends on the ability to translate complex biological concepts and data into clear, actionable insights. The Executive Director must also demonstrate a record of effective cross-functional collaboration throughout the drug development process.